Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jose Coronas
AddedMar 31, 2024
UpdatedMay 1, 2026
Jose Coronas

Jose Coronas

Co-Founder, Thermal Gradient

Jose Coronas's Career

Thermal Gradient
Thermal Gradient

Richmond, VA, US

Co-Founder
New Scale Technologies
New Scale Technologies

Victor, NY, US

Board Member· Board
OyaGen
OyaGen

Rochester, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jose Coronas's Career

Thermal Gradient
Thermal Gradient
Seed$614k82004Richmond, VA, US
Co-Founder

Leadership at Thermal Gradient

Robert D JuncosaRobert D JuncosaCo-Founder

Similar to Thermal Gradient

Fast PCR DiagnosticsFast PCR DiagnosticsArizona, USMedical Diagnostics, PCR Systemsest. 2012Fast PCR DiagnosticsArizona, US · est. 2012

Leading provider of PCR systems for medical diagnostics

Seed · $25k5
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2
Test DiagnosticsTest DiagnosticsNew York City, NY, USDiagnostics, Medical DevicesTest DiagnosticsNew York City, NY, US

NYC-based Test Diagnostics develops Point-of-Care diagnostic technology.

Seed · $334k2
ExactusExactusGlen Allen, VA, USDiagnostics, Healthcareest. 2008ExactusGlen Allen, VA, US · est. 2008

Next-gen Point-of-Care tech firm, Exactus Inc., innovating rapid, cost-effective diagnostics for improved healthcare.

Seed · $4.7M7
New Scale Technologies
New Scale Technologies
Pre-Seed$783.8k262002Victor, NY, US
Board Member· Board

Leadership at New Scale Technologies

Jacob JacobssonJacob JacobssonBoard Member
David HendersonDavid HendersonBoard Member
Ted FranceschiTed FranceschiBoard Member

Similar to New Scale Technologies

NanoMuscleNanoMuscleAntioch, CA, USMotion Technologyest. 1998NanoMuscleAntioch, CA, US · est. 1998

NanoMuscle designs and manufactures advanced, affordable, and compact motion technologies for consumer devices.

Series C · $21M125
Autoscale CNCAutoscale CNCConcord, CA, USCNC Routersest. 2010Autoscale CNCConcord, CA, US · est. 2010

Autoscale CNC Inc: A leading manufacturer of CNC routers and retailer of sewing supplies since 2011.

Seed · $330k2
ResoneticsResoneticsNashua, NH, USMicro Manufacturingest. 1987ResoneticsNashua, NH, US · est. 1987

Leading technical innovator in micro manufacturing for life sciences, specializing in laser operations.

Private Equity · $1.1B30
FinscaleFinscaleDublin, CA, USNanotechnology, Semiconductorsest. 2014FinscaleDublin, CA, US · est. 2014

FinScale, a nanotechnology provider, designs and delivers 3D device integration technologies to enhance electronic devices and systems.

Angel · $180k4
OyaGen
OyaGen
Angel$5.9M62003Rochester, NY, US
Board Member· Board

Leadership at OyaGen

Harold SmithHarold SmithBoard Member
Kevin PhelpsKevin PhelpsBoard Member
Roscoe MooreRoscoe MooreBoard Member
Richard McCloskeyRichard McCloskeyBoard Member

Jose Coronas's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Jose Coronas

Lawrence RosenLawrence RosenBoard Member · LANXESSJose Miguel RamosJose Miguel RamosCo-Founder · EnvelpMikeMikeBoard Member · HTG Molecular DiagnosticsJerry KarabelasJerry KarabelasBoard Member · Human Genome SciencesBob BaumgartnerBob BaumgartnerBoard Member · Bio-Techne